Alton Ochsner Award Relating Smoking and Disease – deadline March 31, 2018

The Alton Ochsner Award recognizes outstanding scientific achievements that have provided pivotal insights into the fundamental biological and clinical mechanisms that relate tobacco consumption with disease. This scientific work may be clinical, fundamental, epidemiological, or prevention in scope.  The prime criterion for award is its scientific context and impact on this major health threat.  All […]

Alzheimer’s Drug Discovery Foundation – funding opportunities 2018

The ADDF offers funding to researchers in both nonprofit and for-profit organizations for Alzheimer’s drug discovery and pre-clinical development, clinical trials, and biomarker development research. Visit our Research Priorities for specific information about our interests. PROGRAM TO ACCELERATE CLINICAL TRIALS Supports Phase 0 through Phase 2 clinical trials, experimental medicine studies in human subjects, and IND-enabling studies. […]

AHRQ – Health Services Research Projects (R01)

Description: The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests […]

AHRQ – Health Services Research Demonstration and Dissemination Grants (R18)

Description: The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R18 research plan proposed by the applicant institution/organization must be related to the mission and priority […]

UVA Global Infectious Disease Institute – seed grants and planning grants

Login required to view this post

Virginia Biosciences Health Research Corporation – life sciences grants

VBHRC, now known as Virginia Catalyst, announced that it is accepting applications/letters of intent (LOIs) for grants to fund the development and commercialization of life science projects that address major unmet needs for improving human health. The awards, which range from $200,000 to $800,000, will accelerate translational research in the Commonwealth of Virginia through collaborations […]

Department of Defense – Accelerating Innovation in Military Medicine (AIMM)

The Department of Defense (DOD) has announced its Accelerating Innovation in Military Medicine (AIMM) initiative managed by the office of Congressionally Directed Medical Research Programs (CDMRP). AIMM Research Award Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcement. The Program Announcement is available electronically for downloading […]

NIH – National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19 Clinical Trial Optional)

Funding Opportunity Purpose: The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and clinical research on mental disorders, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental […]

Crohn’s and Colitis Foundation – Funding for IBD-related novel products

The Crohn’s & Colitis Foundation seeks to accelerate the development of products that aim to improve the quality of life of patients with inflammatory bowel diseases.  Toward that end, the Foundation has launched the Entrepreneurial Investing Initiative, a new program and dedicated funding mechanism to support product-oriented research and development. Companies and academic investigators can apply. […]

NIH – Mechanistic Basis of Diffuse White Matter Disease and Small Vessel Pathology in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 – Clinical Trial Optional)

Small vessel disease and diffuse white matter disease in the brain are highly prevalent in the elderly, and have been clinically and pathologically associated with vascular contributions to cognitive impairment and dementia (VCID) in both men and women. Diffuse white matter disease is thought to include a variety of pathologies including demyelination and/or fiber loss […]